Risk assessment for human developmental neurotoxicity (WP6) Pre- postnatal Screening exposure tools for assessment & neurotoxicity neuro- hazard (WP2) development (WP4) Epidemiology: Timing of exposure in validation genomic, behaviour, cognitive proteomic, and motor function metabolomic markers assessment (WP3) (WP5) Biomarkers for (developmental) neurotoxicity Figure 1: Work packages of DENAMIC. List of beneficiaries DENAMIC. Partner Country Contact person VU Univeristy The Netherlands Pim Leonards IRAS, University Utrecht (IRAS) The Netherlands Milou Dingemans Uppsala University (UU) Sweden Per Eriksson, Henrik Viberg Fundacion de La Comunidad Valenciana Spain Vicente Felipo Centro de Investigacion Principe Felipe (CIPF) Slovak Medical University (SMU) Slovakia Lubica Palkovicova Murinova Callisto Productions Ltd United Kingdom Tom McInnes Center for Public Health Research Spain Marisa Rebagliato Norwegian Institute of Public Health Norway Merete Eggesbø Instituto de Medicina Genomica Spain Javier Garcia-Planells Viewpoint France Didier Neuzeret Proteome Sciences plc United Kingdom Stephan Jung, Ian Pike Institutul National De Cercetare-Dezvoltare Romenia Raluca-Ioana Stefan-van Staden Pentru Electrochimie Si Materie Condensata - INCEMC Gen info Ltd Croatia Ozren Polašek Masarykova Univerzita Czech Republic Anton Kocan DENAMIC film “Young minds at risk? Youtube: https://youtu.be/drcOBcA2mD0 Table 1: List of chemicals studied in DENAMIC. 6-OH-BDE47 deltamethrin oxamyl acrinathrin diazinon paraoxon-ethyl aldicarb DEHP paraoxon-methyl aldrin dichlorvos parathion bifenthrin dicofol PBDE bioallethrin dieldrin PCB carbaryl dimethoate permethrin carbofuran endosulfan PFHxS chlorantraniliprole fenvalerate PFOA chlordane flubendiamide PFOS chlorpyrifos heptachlor pirimicarb chlorpyrifos-oxon hexachlorobenzene propoxur cyfluthrin imidacloprid TCPP cyhalothrin MeHg tetramethrin cypermethrin MEHP TOCP DDD methoate transfluthrin DDE methomyl DDT methiocarb .